Author:
Goodwin Rachel,Giaccone Giuseppe,Calvert Hilary,Lobbezoo Marinus,Eisenhauer Elizabeth A.
Reference14 articles.
1. Contemporary pre-clinical development of anticancer agents – what are the optimal preclinical models?;Damia;Eur J Cancer,2009
2. How much gets there and what does it do?: the need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development;Workman;Curr Pharm Des,2003
3. Envisioning the future of early anticancer drug development;Yap;Nat Rev Cancer,2010
4. Hirschfeld S. Clinical drug trials in children. In: Yaffe S, Aranda Y, editors. Neonatal and pediatric pharmacology. Philadelphia, PA: Lippincott, Williams & Wilkins; 2004. p. 69–91.
5. Eisenhauer EA. Preclinical data and requirements. In: Eisenhauer EA. Twelves C, Buyse M, editors. Phase I cancer clinical trials. UK: Oxford University Press; 2006. p. 11–39.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献